We are live on ! Find out more

462 hedge funds and large institutions have $13.5B invested in Incyte in 2018 Q3 according to their latest regulatory filings, with 57 funds opening new positions, 175 increasing their positions, 156 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 57 | Existing positions closed: 43

29% more funds holding in top 10

Funds holding in top 10: 79 (+2)

12% more repeat investments, than reductions

Existing positions increased: 175 | Existing positions reduced: 156

2% more funds holding

Funds holding: 453462 (+9)

2% more capital invested

Capital invested by funds: $13.2B → $13.5B (+$288M)

1.08% less ownership

Funds ownership: 93.08%91.99% (-1.1%)

19% less call options, than puts

Call options by funds: $174M | Put options by funds: $214M

Holders
462
Holders Change
+9
Holders Change %
+1.99%
% of All Funds
10.52%
Holding in Top 10
9
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+28.57%
% of All Funds
0.2%
New
57
Increased
175
Reduced
156
Closed
43
Calls
$174M
Puts
$214M
Net Calls
-$40.4M
Net Calls Change
+$22.3M

INCY Hedge Fund Activity: Q3 2018 in Review

462 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in Incyte (INCY) for Q3 2018, worth a combined $13.5B — up 2.2% from $13.2B a quarter earlier.

Buyers outnumbered sellers: 57 funds opened new INCY positions and 43 closed out — a net gain of 14 holders — while 175 added to existing stakes and 156 trimmed.

The largest buyer was OppenheimerFunds, opening a new position worth an estimated $122M. The largest seller was UBS Group, cutting an estimated $179M.

  • 462 institutional investors held Incyte (INCY) as of Q3 2018, up from 453 in Q2 2018.
  • Funds reported $13.5B of Incyte stock for Q3 2018, up 2.2% quarter-over-quarter.
  • 57 funds opened new Incyte positions in Q3 2018 and 43 closed out, a net change of +14 holders.
  • The largest Incyte buyer in Q3 2018 was OppenheimerFunds, an estimated $122M added.
  • The largest Incyte seller in Q3 2018 was UBS Group, an estimated $179M sold.

Based on aggregated 13F filings for Q3 2018.